Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Pharmaceutical Statistics
|
December 15, 2012
On the practical application of mixed effects models for repeated measures to clinical trial data
Scott W Andersen, Brian A Millen
Journal of Biopharmaceutical Statistics
|
January 8, 2014
Bayesian assessment of the influence and interaction conditions in multipopulation tailoring clinical trials
Brian A Millen, Alex Dmitrienko, Guochen Song
Journal of Biopharmaceutical Statistics
|
April 26, 2011
Three methods for constructing parallel gatekeeping procedures in clinical trials
Alex Dmitrienko, Julia N Soulakova, Brian A Millen
Journal of Psychopharmacology (Oxford, England)
|
June 19, 2010
Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials
Brian A Millen, Giedra M Campbell, Charles M Beasley
Biometrical Journal. Biometrische Zeitschrift
|
November 10, 2011
Development of gatekeeping strategies in confirmatory clinical trials
Alex Dmitrienko, Brian A Millen, Thomas Brechenmacher, et al.
Psychopharmacology Bulletin
|
June 29, 2010
Signal detection and placebo response in schizophrenia: parallels with depression
Craig H Mallinckrodt, Lu Zhang, William R Prucka, et al.
Biological Psychiatry
|
April 20, 2015
Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia
Bruce J Kinon, Brian A Millen, Lu Zhang, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations
Brian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Schizophrenia Research and Treatment
|
April 29, 2014
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison
David H Adams, Lu Zhang, Brian A Millen, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 1, 2012
Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine
Ludmila A Kryzhanovskaya, Wen Xu, Brian A Millen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Pharmaceutical Statistics
|
December 15, 2012
On the practical application of mixed effects models for repeated measures to clinical trial data
Scott W Andersen, Brian A Millen
Journal of Biopharmaceutical Statistics
|
January 8, 2014
Bayesian assessment of the influence and interaction conditions in multipopulation tailoring clinical trials
Brian A Millen, Alex Dmitrienko, Guochen Song
Journal of Biopharmaceutical Statistics
|
April 26, 2011
Three methods for constructing parallel gatekeeping procedures in clinical trials
Alex Dmitrienko, Julia N Soulakova, Brian A Millen
Journal of Psychopharmacology (Oxford, England)
|
June 19, 2010
Weight changes over time in adults treated with the oral or depot formulations of olanzapine: a pooled analysis of 86 clinical trials
Brian A Millen, Giedra M Campbell, Charles M Beasley
Biometrical Journal. Biometrische Zeitschrift
|
November 10, 2011
Development of gatekeeping strategies in confirmatory clinical trials
Alex Dmitrienko, Brian A Millen, Thomas Brechenmacher, et al.
Psychopharmacology Bulletin
|
June 29, 2010
Signal detection and placebo response in schizophrenia: parallels with depression
Craig H Mallinckrodt, Lu Zhang, William R Prucka, et al.
Biological Psychiatry
|
April 20, 2015
Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophrenia
Bruce J Kinon, Brian A Millen, Lu Zhang, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference Considerations
Brian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Schizophrenia Research and Treatment
|
April 29, 2014
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison
David H Adams, Lu Zhang, Brian A Millen, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 1, 2012
Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapine
Ludmila A Kryzhanovskaya, Wen Xu, Brian A Millen, et al.
Page
of 2